01 12VERTEX PHARMS INC
01 1211578062
01 12Blank
01 12Y
01 122031-03-25
Patent Expiration Date : 2031-03-25
ELEXACAFTOR, IVACAFTOR, TEZACAFTOR; IVACAFTOR
US Patent Number : 11578062
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 217660
Patent Use Code : U-4054
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2031-03-25
Patent Expiration Date : 2031-03-25
DEUTIVACAFTOR; TEZACAFTOR; VANZACAFTOR CALCIUM
US Patent Number : 11578062
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 218730
Patent Use Code : U-4096
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2031-03-25
Patent Expiration Date : 2031-03-25
ELEXACAFTOR, IVACAFTOR, TEZACAFTOR; IVACAFTOR
US Patent Number : 11578062
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 217660
Patent Use Code : U-3584
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2031-03-25
Patent Expiration Date : 2031-03-25
ELEXACAFTOR, IVACAFTOR, TEZACAFTOR; IVACAFTOR
US Patent Number : 11578062
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 212273
Patent Use Code : U-4054
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2031-03-25
Patent Expiration Date : 2031-03-25
IVACAFTOR; IVACAFTOR, TEZACAFTOR
US Patent Number : 11578062
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 210491
Patent Use Code : U-3545
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2031-03-25
Patent Expiration Date : 2031-03-25
ELEXACAFTOR, IVACAFTOR, TEZACAFTOR; IVACAFTOR
US Patent Number : 11578062
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 212273
Patent Use Code : U-3544
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2031-03-25
Patent Expiration Date : 2031-03-25
DEUTIVACAFTOR; TEZACAFTOR; VANZACAFTOR CALCIUM
US Patent Number : 11578062
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 218730
Patent Use Code : U-4096
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2031-03-25
Patent Expiration Date : 2031-03-25
ELEXACAFTOR, IVACAFTOR, TEZACAFTOR; IVACAFTOR
US Patent Number : 11578062
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 212273
Patent Use Code : U-4054
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2031-03-25
Patent Expiration Date : 2031-03-25
ELEXACAFTOR, IVACAFTOR, TEZACAFTOR; IVACAFTOR
US Patent Number : 11578062
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 217660
Patent Use Code : U-3584
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2031-03-25
Patent Expiration Date : 2031-03-25
IVACAFTOR; IVACAFTOR, TEZACAFTOR
US Patent Number : 11578062
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 210491
Patent Use Code : U-3545
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2031-03-25
